RAB39B is abnormally elevated and associated with drug resistance and poor OS in DLBCL, which may be related to its involvement in immune infiltration, m6A modification, and regulation by multiple non-coding RNAs. This evidence concerns the gene RAB39B and diffuse large B-cell lymphoma.